Performance for Lobectomy Compared to STS and National Outcomes*
* These NIS data are the most recent data available at this time. There are more lobectomy for lung cancer patients in a single year of NIS data than in the GTSD, so a decision was made to use 3 years of STS GTSD data.
Lobectomy for Lung Cancer Composite Measure Rating (July 2020 - June 2023)
Overall Composite Score |
98.4%
(97.8 - 99.0)
|
98.4% (97.8, 99)
Participant Score
Participant Credible Interval
STS Range
STS Average Score
|
As Expected
|
Absence of Operative Mortality |
98.5%
(97.2 - 99.2)
|
98.5% (97.2, 99.2)
Participant Score
Participant Credible Interval
STS Range
STS Average Score
|
As Expected
|
Absence of Major Morbidity |
93.9%
(91.0 - 96.2)
|
93.9% (91, 96.2)
Participant Score
Participant Credible Interval
STS Range
STS Average Score
|
As Expected
|
Esophagectomy Composite Measure Rating (July 2020 - June 2023)
Participant is not enrolled in public reporting for Esophagectomy but does publicly report for at least one other procedure. |
*Lobectomy for Lung Cancer Overall Composite Score represents two domain scores in a single number:
-
Absence of Operative Mortality: Percentage of patients [risk-adjusted] who did not experience operative mortality. Operative mortality is defined as death during the same hospitalization as surgery or after discharge but within 30 days of the procedure.
-
Absence of Major Morbidity: Percentage of patients [risk-adjusted] who did not experience any major complication. These are: 1) pneumonia; 2) acute respiratory distress syndrome; 3) bronchopleural fistula; 4) pulmonary embolus; 5) initial ventilator support > 48 hours; 6) reintubation; 7) tracheostomy; 8) myocardial infarction; 9) unexpected return to the operating room.
** Esophagectomy Overall Composite Score represents two domain scores in a single number:
-
Absence of Operative Mortality: Percentage of patients [risk-adjusted] who did not experience operative mortality. Operative mortality is defined as death during the same hospitalization as surgery or after discharge but within 30 days of the procedure.
-
Absence of Major Morbidity: Percentage of patients [risk-adjusted] who did not experience any major complication. These are: 1) pneumonia; 2) recurrent laryngeal nerve paresis; 3) anastomotic leak requiring medical treatment only; 4) initial ventilator support > 48 hours; 5) respiratory failure; 6) unexpected return to the operating room; 7) new renal failure per RIFLE criteria.